National Centre for Clinical Research on Emerging Drugs
About
In recent decades, authors affiliated with National Centre for Clinical Research on Emerging Drugs have published 1.5k papers, which have received a total of 76.8k indexed citations.
Scholars at this organization have produced 682 papers in Epidemiology, 572 papers in Infectious Diseases and 323 papers in Virology on the topics of Prevention and Treatment of HIV/AIDS Infection (433 papers), HIV Research and Treatment (320 papers) and HIV, Drug Use, Sexual Risk (306 papers). Their work is cited by papers focused on Epidemiology (31.9k citations), Infectious Diseases (25.9k citations) and Virology (15.6k citations). Authors at National Centre for Clinical Research on Emerging Drugs collaborate with scholars in Australia, United States and United Kingdom and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet. Some of National Centre for Clinical Research on Emerging Drugs's most productive authors include John Kaldor, Matthew Law, David A. Cooper, Gregory J. Dore and Andrew E. Grulich
In The Last Decade
Explore institutions with similar magnitude of impact
Top fields scholars at Nanosystems Initiative Munich are working on Top journals impacted by scholars at Foundation for Biomedical Research Top qs scholars at Kitt Peak National Observatory are publish in journals categorized as Top qs scholars at Ottawa Regional Cancer Foundation are publish in journals categorized as Top countries impacted by scholars at Atlanta University Center Top countries impacted by scholars at Signature Healthcare Brockton Hospital Top countries impacted by scholars at Epilepsy Society Top fields scholars at Blood Cancer UK are working on